KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

ClearPoint Neuro (CLPT) Gross Margin (2018 - 2025)

Historic Gross Margin for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to 63.2%.

  • ClearPoint Neuro's Gross Margin rose 35200.0% to 63.2% in Q3 2025 from the same period last year, while for Sep 2025 it was 61.31%, marking a year-over-year increase of 9300.0%. This contributed to the annual value of 60.92% for FY2024, which is 40900.0% up from last year.
  • ClearPoint Neuro's Gross Margin amounted to 63.2% in Q3 2025, which was up 35200.0% from 60.29% recorded in Q2 2025.
  • Over the past 5 years, ClearPoint Neuro's Gross Margin peaked at 74.36% during Q4 2021, and registered a low of 52.54% during Q2 2023.
  • Over the past 5 years, ClearPoint Neuro's median Gross Margin value was 62.6% (recorded in 2022), while the average stood at 62.66%.
  • In the last 5 years, ClearPoint Neuro's Gross Margin plummeted by -146900bps in 2023 and then soared by 109400bps in 2024.
  • Quarter analysis of 5 years shows ClearPoint Neuro's Gross Margin stood at 74.36% in 2021, then fell by -13bps to 65.06% in 2022, then dropped by -9bps to 58.93% in 2023, then rose by 4bps to 61.28% in 2024, then rose by 3bps to 63.2% in 2025.
  • Its Gross Margin was 63.2% in Q3 2025, compared to 60.29% in Q2 2025 and 60.48% in Q1 2025.